D. Grahame Hardie 12th International Meeting on AMPK 2023

D. Grahame Hardie

Grahame Hardie became Professor of Cellular Signalling at Dundee University in 1994. He is a Fellow of the Royal Society, the Royal Society of Edinburgh, and the UK Academy of Medical Sciences. He was awarded the Rolf Luft prize for Endocrinology and Metabolism of the Karolinska Institute in 2008, the Novartis Medal and Philip Randle Prize Lecture of the UK Biochemical Society in 2010 and 2022, and the Solomon Berson Distinguished Lectureship of the American Physiological Society in 2015. He has received an honorary degree from the Medical University of Bialystok, Poland, and was a Distinguished Visiting Professor at the Universities of Hong Kong and Xiamen, China. Grahame originally defined and named the AMP-activated protein kinase (AMPK) system and demonstrated that it maintained energy balance at the cellular and whole-body levels. He and others discovered that the tumour suppressor LKB1 acted upstream of AMPK, which led to the current worldwide interest in the role of AMPK in cancer.